 | • レポートコード：B-GIR09F3155 • 出版社/出版日：GlobalInfoResearch / 2019年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール • 産業分類：Medical Care |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、間質性膀胱炎薬の世界市場について調べ、まとめました。種類別セグメントは、経口療法、膀胱内療法等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。間質性膀胱炎薬の世界市場概観、企業動向、企業別間質性膀胱炎薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・間質性膀胱炎薬の市場概観 ・間質性膀胱炎薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・間質性膀胱炎薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・間質性膀胱炎薬の世界市場規模 ・間質性膀胱炎薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・間質性膀胱炎薬のアメリカ市場規模推移 ・間質性膀胱炎薬のカナダ市場規模推移 ・間質性膀胱炎薬のメキシコ市場規模推移 ・間質性膀胱炎薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・間質性膀胱炎薬のドイツ市場規模推移 ・間質性膀胱炎薬のイギリス市場規模推移 ・間質性膀胱炎薬のロシア市場規模推移 ・間質性膀胱炎薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・間質性膀胱炎薬の日本市場規模推移 ・間質性膀胱炎薬の中国市場規模推移 ・間質性膀胱炎薬の韓国市場規模推移 ・間質性膀胱炎薬のインド市場規模推移 ・間質性膀胱炎薬の東南アジア市場規模推移 ・間質性膀胱炎薬の南米市場分析（ブラジル、アルゼンチン等） ・間質性膀胱炎薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・間質性膀胱炎薬の種類別分析/販売量、売上、市場シェア（経口療法、膀胱内療法） ・間質性膀胱炎薬の用途別分析/市場規模（病院薬局、小売薬局、オンライン薬局） ・間質性膀胱炎薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・間質性膀胱炎薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Interstitial cystitis (IC), also known as painful bladder syndrome, is a chronic bladder issue often associated with bladder pressure and pain, with occasional pain in either the lower abdomen, pelvic, or lower back.
Scope of the Report:
The global Interstitial Cystitis Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Interstitial Cystitis Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Interstitial Cystitis Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Interstitial Cystitis Drugs market by product type and applications/end industries.
Market Segment by Companies, this report covers
Pfizer
Bayer
Eli Lilly
Johnson & Johnson
Mylan
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral Therapy
Intravesical Therapy
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Table of Contents
1 Interstitial Cystitis Drugs Market Overview
1.1 Product Overview and Scope of Interstitial Cystitis Drugs
1.2 Classification of Interstitial Cystitis Drugs by Types
1.2.1 Global Interstitial Cystitis Drugs Revenue Comparison by Types (2019-2024)
1.2.2 Global Interstitial Cystitis Drugs Revenue Market Share by Types in 2018
1.2.3 Oral Therapy
1.2.4 Intravesical Therapy
1.3 Global Interstitial Cystitis Drugs Market by Application
1.3.1 Global Interstitial Cystitis Drugs Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Interstitial Cystitis Drugs Market by Regions
1.4.1 Global Interstitial Cystitis Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Interstitial Cystitis Drugs Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Interstitial Cystitis Drugs Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Interstitial Cystitis Drugs Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Interstitial Cystitis Drugs Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Interstitial Cystitis Drugs Status and Prospect (2014-2024)
1.5 Global Market Size of Interstitial Cystitis Drugs (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Interstitial Cystitis Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Interstitial Cystitis Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bayer
2.2.1 Business Overview
2.2.2 Interstitial Cystitis Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer Interstitial Cystitis Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.3 Eli Lilly
2.3.1 Business Overview
2.3.2 Interstitial Cystitis Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eli Lilly Interstitial Cystitis Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.2 Interstitial Cystitis Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson & Johnson Interstitial Cystitis Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.5 Mylan
2.5.1 Business Overview
2.5.2 Interstitial Cystitis Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Mylan Interstitial Cystitis Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global Interstitial Cystitis Drugs Market Competition, by Players
3.1 Global Interstitial Cystitis Drugs Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Interstitial Cystitis Drugs Players Market Share
3.2.2 Top 10 Interstitial Cystitis Drugs Players Market Share
3.3 Market Competition Trend
4 Global Interstitial Cystitis Drugs Market Size by Regions
4.1 Global Interstitial Cystitis Drugs Revenue and Market Share by Regions
4.2 North America Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
4.3 Europe Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
4.5 South America Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
5 North America Interstitial Cystitis Drugs Revenue by Countries
5.1 North America Interstitial Cystitis Drugs Revenue by Countries (2014-2019)
5.2 USA Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
5.3 Canada Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
5.4 Mexico Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
6 Europe Interstitial Cystitis Drugs Revenue by Countries
6.1 Europe Interstitial Cystitis Drugs Revenue by Countries (2014-2019)
6.2 Germany Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
6.3 UK Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
6.4 France Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
6.5 Russia Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
6.6 Italy Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Interstitial Cystitis Drugs Revenue by Countries
7.1 Asia-Pacific Interstitial Cystitis Drugs Revenue by Countries (2014-2019)
7.2 China Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
7.3 Japan Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
7.4 Korea Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
7.5 India Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
8 South America Interstitial Cystitis Drugs Revenue by Countries
8.1 South America Interstitial Cystitis Drugs Revenue by Countries (2014-2019)
8.2 Brazil Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
8.3 Argentina Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
8.4 Colombia Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Interstitial Cystitis Drugs by Countries
9.1 Middle East and Africa Interstitial Cystitis Drugs Revenue by Countries (2014-2019)
9.2 Saudi Arabia Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
9.3 UAE Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
9.4 Egypt Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
9.5 Nigeria Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
9.6 South Africa Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
10 Global Interstitial Cystitis Drugs Market Segment by Type
10.1 Global Interstitial Cystitis Drugs Revenue and Market Share by Type (2014-2019)
10.2 Global Interstitial Cystitis Drugs Market Forecast by Type (2019-2024)
10.3 Oral Therapy Revenue Growth Rate (2014-2024)
10.4 Intravesical Therapy Revenue Growth Rate (2014-2024)
11 Global Interstitial Cystitis Drugs Market Segment by Application
11.1 Global Interstitial Cystitis Drugs Revenue Market Share by Application (2014-2019)
11.2 Interstitial Cystitis Drugs Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2014-2019)
11.4 Retail Pharmacies Revenue Growth (2014-2019)
11.5 Online Pharmacies Revenue Growth (2014-2019)
12 Global Interstitial Cystitis Drugs Market Size Forecast (2019-2024)
12.1 Global Interstitial Cystitis Drugs Market Size Forecast (2019-2024)
12.2 Global Interstitial Cystitis Drugs Market Forecast by Regions (2019-2024)
12.3 North America Interstitial Cystitis Drugs Revenue Market Forecast (2019-2024)
12.4 Europe Interstitial Cystitis Drugs Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Interstitial Cystitis Drugs Revenue Market Forecast (2019-2024)
12.6 South America Interstitial Cystitis Drugs Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Interstitial Cystitis Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Interstitial Cystitis Drugs Picture
Table Product Specifications of Interstitial Cystitis Drugs
Table Global Interstitial Cystitis Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Interstitial Cystitis Drugs Revenue Market Share by Types in 2018
Figure Oral Therapy Picture
Figure Intravesical Therapy Picture
Table Global Interstitial Cystitis Drugs Revenue (Million USD) by Application (2014-2024)
Figure Interstitial Cystitis Drugs Revenue Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Market Interstitial Cystitis Drugs Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Interstitial Cystitis Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Interstitial Cystitis Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Interstitial Cystitis Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Interstitial Cystitis Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Interstitial Cystitis Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Interstitial Cystitis Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Interstitial Cystitis Drugs Type and Applications
Table Pfizer Interstitial Cystitis Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Interstitial Cystitis Drugs Type and Applications
Table Bayer Interstitial Cystitis Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Interstitial Cystitis Drugs Type and Applications
Table Eli Lilly Interstitial Cystitis Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Interstitial Cystitis Drugs Type and Applications
Table Johnson & Johnson Interstitial Cystitis Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Interstitial Cystitis Drugs Type and Applications
Table Mylan Interstitial Cystitis Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Global Interstitial Cystitis Drugs Revenue (Million USD) by Players (2014-2019)
Table Global Interstitial Cystitis Drugs Revenue Share by Players (2014-2019)
Figure Global Interstitial Cystitis Drugs Revenue Share by Players in 2017
Figure Global Interstitial Cystitis Drugs Revenue Share by Players in 2018
Figure Global Top 5 Players Interstitial Cystitis Drugs Revenue Market Share in 2018
Figure Global Top 10 Players Interstitial Cystitis Drugs Revenue Market Share in 2018
Figure Global Interstitial Cystitis Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Interstitial Cystitis Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Interstitial Cystitis Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Interstitial Cystitis Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Interstitial Cystitis Drugs Revenue Market Share by Regions in 2018
Figure North America Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Figure Europe Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Figure South America Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Table North America Interstitial Cystitis Drugs Revenue by Countries (2014-2019)
Table North America Interstitial Cystitis Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Interstitial Cystitis Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Interstitial Cystitis Drugs Revenue Market Share by Countries in 2018
Figure USA Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Figure Canada Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Figure Mexico Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Table Europe Interstitial Cystitis Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Europe Interstitial Cystitis Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Interstitial Cystitis Drugs Revenue Market Share by Countries in 2018
Figure Germany Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Figure UK Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Figure France Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Figure Russia Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Figure Italy Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Interstitial Cystitis Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Interstitial Cystitis Drugs Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Interstitial Cystitis Drugs Revenue Market Share by Countries in 2018
Figure China Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Figure Japan Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Figure Korea Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Figure India Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Table South America Interstitial Cystitis Drugs Revenue by Countries (2014-2019)
Table South America Interstitial Cystitis Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Interstitial Cystitis Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Interstitial Cystitis Drugs Revenue Market Share by Countries in 2018
Figure Brazil Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Figure Argentina Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Figure Colombia Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Interstitial Cystitis Drugs Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Interstitial Cystitis Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Interstitial Cystitis Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Interstitial Cystitis Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Figure UAE Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Figure Egypt Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Figure Nigeria Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Figure South Africa Interstitial Cystitis Drugs Revenue and Growth Rate (2014-2019)
Table Global Interstitial Cystitis Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Interstitial Cystitis Drugs Revenue Share by Type (2014-2019)
Figure Global Interstitial Cystitis Drugs Revenue Share by Type (2014-2019)
Figure Global Interstitial Cystitis Drugs Revenue Share by Type in 2019
Table Global Interstitial Cystitis Drugs Revenue Forecast by Type (2019-2024)
Figure Global Interstitial Cystitis Drugs Market Share Forecast by Type (2019-2024)
Figure Global Oral Therapy Revenue Growth Rate (2014-2019)
Figure Global Intravesical Therapy Revenue Growth Rate (2014-2019)
Table Global Interstitial Cystitis Drugs Revenue by Application (2014-2019)
Table Global Interstitial Cystitis Drugs Revenue Share by Application (2014-2019)
Figure Global Interstitial Cystitis Drugs Revenue Share by Application (2014-2019)
Figure Global Interstitial Cystitis Drugs Revenue Share by Application in 2019
Table Global Interstitial Cystitis Drugs Revenue Forecast by Application (2019-2024)
Figure Global Interstitial Cystitis Drugs Market Share Forecast by Application (2019-2024)
Figure Global Hospital Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Retail Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Online Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Interstitial Cystitis Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Interstitial Cystitis Drugs Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Interstitial Cystitis Drugs Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Interstitial Cystitis Drugs Revenue Market Forecast (2019-2024)
Figure Europe Interstitial Cystitis Drugs Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Interstitial Cystitis Drugs Revenue Market Forecast (2019-2024)
Figure South America Interstitial Cystitis Drugs Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Interstitial Cystitis Drugs Revenue Market Forecast (2019-2024)
世界のがんホルモン療法薬市場予測（～2024年） Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer. Scope of the Report: The global Cancer Hormon…- 世界のホジキンリンパ腫薬市場予測（～2024年） Hodgkin's lymphoma is a type of lymphoma in which cancer originates from a specific type of white blood cells called lymphocytes. Symptoms may include fever, night sweats, and weight loss. Often there will be non-painful enlarged lymph nodes in the neck, under the arm, or in the groin. Those affecte…
- 世界の婦人科薬市場予測（～2024年）：企業別、地域別、種類・用途別 Scope of the Report: The global Gynecology Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fas…
- 世界のボツリヌス中毒症薬市場予測（～2024年） Botulism is a rare and potentially fatal illness caused by a toxin produced by the bacterium Clostridium botulinum. The disease begins with weakness, blurred vision, feeling tired, and trouble speaking. This may then be followed by weakness of the arms, chest muscles, and legs. Vomiting, swelling of…
- 世界のがんサポーティブケア薬市場予測（～2024年）：企業別、地域別、種類・用途別 Scope of the Report: The global Cancer Supportive Care Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in Chi…